Members of the CARE™ Oncology faculty attended the American Society of Clinical Oncology (ASCO 2019) annual meeting from May 31st – June 4th in Chicago, IL.
While ASCO 2019 featured coverage on many different types of oncology, this section of the CARE™ Perspectives: ASCO 2019 report summarizes news and updates in Lung Cancer with emphasis on Immuno-Oncology, EGFR and Targeted Therapies.
This report was created in collaboration with CARE™ Oncology faculty members:
Dr. Barb Melosky (BCCA, Vancouver)
Dr. Normand Blais (CHUM, Montreal)
with additional review from Dr. Randeep Sangha (Cross Cancer Institute, Edmonton).
All available sections of the ASCO 2019 report: